← brief for 2026-10-18 · Slowing decline

GLP-1 receptor agonist therapy and incident atrial fibrillation in non-diabetic adults with obesity and chronic kidney disease: a propensity matched cohort study.

Article C Peer reviewed Observational

Key takeaways

This study compared 10,985 people on GLP-1 drugs with 94,527 people not on them. All had obesity and kidney disease but no diabetes. It looked at whether the drugs prevented a type of irregular heartbeat. This shows a link, not proof of cause. It helps doctors weigh the benefits of these drugs.

Who did this work

Hassan A · Okorigba E · Grace C · Otabor E · Osineye B · Olayiwola O · Oyeleye T · Amin P

Source

Article · PubMed, the drug frontier · 2026 Oct 17
https://pubmed.ncbi.nlm.nih.gov/42892471/